Artificial Lung Market - Global Forecast 2025-2032

The artificial lung market is entering a phase of accelerated transformation, driven by renewed clinical priorities and sustained innovation across devices, care models, and supply infrastructure. Senior leaders must quickly interpret trends and uncover strategic levers that shape long-term value and adaptability in this evolving sector.

Market Snapshot: Artificial Lung Market Size and Growth

The artificial lung market expanded from USD 7.63 billion in 2024 to USD 8.33 billion in 2025, with projections indicating ongoing expansion at a CAGR of 9.02% to reach USD 15.24 billion by 2032. Growth momentum is supported by advancements in respiratory technology, stronger demands for improved patient outcomes, and robust global investment in healthcare infrastructure modernization. Shifts span both critical and outpatient care, prompting established firms and new entrants to revisit product strategies, bolster supply resilience, and invest continually in innovation across their artificial lung market portfolios.

Scope & Segmentation Overview

This report provides senior decision-makers with targeted insight into pivotal shifts, emerging product opportunities, and active competitive forces shaping the artificial lung industry. Analysis spans the entire value chain, equipping executives to prioritize business segments and allocate resources based on specific market drivers and operational requirements:

• Product Types: Coverage includes extracorporeal membrane oxygenation systems, implantable artificial lung devices, cannulas, consoles, oxygenators, and pumps—each crucial for addressing patient needs in acute and chronic respiratory care.
• Technologies: Examines ceramic, flat sheet, and hollow fiber membrane designs, with focused analysis on material durability and the application of polyethersulfone and polypropylene for enhanced biocompatibility.
• End Users: Segmentation includes hospitals, ambulatory care centers, and home care organizations, reflecting changing care models and the growth of decentralized respiratory support options.
• Applications: Reviews usage in critical care, emergency transport, and respiratory support, especially regarding adoption in trauma intervention and long-term disease management settings.
• Distribution Channels: Highlights direct sales to clinics and hospitals, reliance on distributor networks, and the emerging significance of online procurement platforms for streamlined, international product access.
• Material Types: Assesses performance attributes of polyethersulfone, polypropylene, and silicone as prioritized for safety, efficiency, and scalable production.
• Regions: Analysis includes Americas, Europe, Middle East, Africa, and Asia Pacific, with detailed focus on North America, Latin America, European Union, Middle East, Africa, and key Asia Pacific markets to account for varying clinical requirements and regulatory environments.
• Companies Analyzed: The report delivers insight into industry participants such as Getinge AB, LivaNova PLC, Medtronic PLC, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, MC3 Cardiopulmonary Support Inc., SynCardia Systems, LLC, ALung Technologies, Inc., Aeson Cardiovascular AG, and Hemovent GmbH, showcasing a full spectrum of competitive positioning and technology adoption.

Key Takeaways for Decision Makers

• Innovations are propelling compact extracorporeal platforms and new implantable devices that address both acute incidents and ongoing respiratory care across diverse clinical scenarios.
• Differentiation strategies hinge on proprietary membrane technologies, advancement in microfluidic engineering, and digital health integration to improve device safety and support better patient outcomes.
• Organizations are rebalancing supply chains by diversifying sourcing and prioritizing near-shoring to minimize disruptions and contain operational expenditures within complex global trade structures.
• Customer demand is increasing for adaptable, high-performance devices to serve hospitals, emergency responders, and a swiftly growing segment focused on home-based respiratory management.
• Collaborative efforts between manufacturers, research institutions, and supply specialists are expediting development timelines and reinforcing clinical support networks to meet evolving user requirements.

Tariff Impact and Strategic Response

Recent United States tariff adjustments have imposed higher duties on artificial lung components sourced from Asia, raising overall landed costs and challenging pricing strategies in cost-sensitive healthcare environments. Industry leaders are responding with near-shoring initiatives, forming regional sourcing partnerships, and refining inventory strategies to ensure supply continuity and maintain quality standards.

Methodology & Data Sources

This research synthesizes insights from primary interviews with pulmonologists, device engineers, procurement managers, and regulatory experts alongside a thorough secondary review of peer-reviewed journals, patent databases, and clinical records. Findings are validated through data triangulation and expert cross-referencing to ensure reliability for decision use.

Artificial Lung Market: Why This Report Matters

• Enables senior teams to align capital investments, identify strategic partnerships, and prioritize R&D in line with changing regulatory and clinical demands.
• Delivers actionable direction for leadership on innovation pathways, expanding regional opportunities, and robust supply strategies for sustainable market presence.
• Equips operational leaders to streamline product development, optimize regulatory compliance, and strengthen distribution systems supporting both centralized and home care models.

Conclusion

The artificial lung market is experiencing rapid shifts, with refreshed product approaches and collaborative networks enhancing sector resilience. Future growth will rely on adaptable strategies and focused investments to optimize patient access and sustain competitive position.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.